Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination.
Richardson E, Bibi S, McLean F, Schimanski L, Rijal P, Ghraichy M, von Niederhäusern V, Trück J, Clutterbuck EA, O'Connor D, Luhn K, Townsend A, Peters B, Pollard AJ, Deane CM, Kelly DF. Richardson E, et al. Among authors: schimanski l. Front Immunol. 2024 Jul 8;15:1383753. doi: 10.3389/fimmu.2024.1383753. eCollection 2024. Front Immunol. 2024. PMID: 39040106 Free PMC article. Clinical Trial.
A broadly-neutralizing antibody against Ebolavirus glycoprotein that potentiates the breadth and neutralization potency of other antibodies.
Donnellan FR, Rayaprolu V, Rijal P, O'Dowd V, Parvate A, Callaway H, Hariharan C, Parekh D, Hui S, Shaffer K, Avalos RD, Hastie K, Schimanski L, Müller-Kräuter H, Strecker T, Balaram A, Halfmann P, Saphire EO, Lightwood DJ, Townsend AR, Draper SJ. Donnellan FR, et al. Among authors: schimanski l. bioRxiv [Preprint]. 2024 Jun 25:2024.06.21.600001. doi: 10.1101/2024.06.21.600001. bioRxiv. 2024. PMID: 38979279 Free PMC article. Preprint.
The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine.
Chen X, Mohapatra A, Nguyen HTV, Schimanski L, Kit Tan T, Rijal P, Chen CP, Cheng SH, Lee WH, Chou YC, Townsend AR, Ma C, Huang KA. Chen X, et al. Among authors: schimanski l. PLoS Pathog. 2024 Jun 10;20(6):e1012246. doi: 10.1371/journal.ppat.1012246. eCollection 2024 Jun. PLoS Pathog. 2024. PMID: 38857264 Free PMC article.
Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2.
Huang KA, Chen X, Mohapatra A, Nguyen HTV, Schimanski L, Tan TK, Rijal P, Vester SK, Hills RA, Howarth M, Keeffe JR, Cohen AA, Kakutani LM, Wu YM, Shahed-Al-Mahmud M, Chou YC, Bjorkman PJ, Townsend AR, Ma C. Huang KA, et al. Among authors: schimanski l. Nat Commun. 2023 Jan 19;14(1):311. doi: 10.1038/s41467-023-35949-8. Nat Commun. 2023. PMID: 36658148 Free PMC article.
Immune responses to Sinopharm/BBIBP-CorV in individuals in Sri Lanka.
Jeewandara C, Aberathna IS, Pushpakumara PD, Kamaladasa A, Guruge D, Wijesinghe A, Gunasekera B, Tanussiya S, Kuruppu H, Ranasinghe T, Dayarathne S, Dissanayake O, Gamalath N, Ekanayake D, Jayamali J, Jayathilaka D, Dissanayake M, Madusanka D, Jayadas TT, Mudunkotuwa A, Somathilake G, Harvie M, Nimasha T, Danasekara S, Wijayamuni R, Schimanski L, Rijal P, Tan TK, Dong T, Townsend A, Ogg GS, Malavige GN. Jeewandara C, et al. Among authors: schimanski l. Immunology. 2022 Oct;167(2):275-285. doi: 10.1111/imm.13536. Epub 2022 Jul 12. Immunology. 2022. PMID: 35758860 Free PMC article.
Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka.
Jeewandara C, Aberathna IS, Danasekara S, Gomes L, Fernando S, Guruge D, Ranasinghe T, Gunasekera B, Kamaladasa A, Kuruppu H, Somathilake G, Jayamali J, Jayathilaka D, Wijayatilake HDK, Pushpakumara PD, Harvie M, Nimasha T, de Silva SDG, Wijayamuni R, Schimanski L, Rijal P, Tan J, Townsend A, Ogg GS, Malavige GN. Jeewandara C, et al. Among authors: schimanski l. Immunology. 2022 Oct;167(2):263-274. doi: 10.1111/imm.13535. Epub 2022 Jul 9. Immunology. 2022. PMID: 35751563 Free PMC article.
Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222.
Jayathilaka D, Jeewandara C, Gomes L, Jayadas TTP, Kamaladasa A, Somathilake G, Guruge D, Pushpakumara PD, Ranasinghe T, Aberathna IS, Danasekara S, Gunathilaka B, Kuruppu H, Wijewickrama A, Wijayamuni R, Schimanski L, Tan TK, Ogg GS, Townsend A, Malavige GN. Jayathilaka D, et al. Among authors: schimanski l. Clin Exp Immunol. 2022 Jun 23;208(3):323-331. doi: 10.1093/cei/uxac009. Clin Exp Immunol. 2022. PMID: 35641142 Free PMC article.
Persistence of immune responses to the Sinopharm/BBIBP-CorV vaccine.
Jeewandara C, Aberathna IS, Pushpakumara PD, Kamaladasa A, Guruge D, Wijesinghe A, Gunasekera B, Ramu ST, Kuruppu H, Ranasinghe T, Dayarathna S, Dissanayake O, Gamalath N, Ekanayake D, Jayamali J, Jayathilaka D, Dissanayake M, Jayadas TT, Mudunkotuwa A, Somathilake G, Harvie M, Nimasha T, Danasekara S, Wijayamuni R, Schimanski L, Rijal P, Tan TK, Dong T, Townsend A, Ogg GS, Malavige GN. Jeewandara C, et al. Among authors: schimanski l. Immun Inflamm Dis. 2022 Jun;10(6):e621. doi: 10.1002/iid3.621. Immun Inflamm Dis. 2022. PMID: 35634958 Free PMC article.
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern.
Ertesvåg NU, Xiao J, Zhou F, Ljostveit S, Sandnes H, Lartey S, Sævik M, Hansen L, Madsen A, Mohn KGI, Fjelltveit E, Olofsson JS, Tan TK, Rijal P, Schimanski L, Øyen S, Brokstad KA, Dunachie S, Jämsén A, James WS, Harding AC, Harvala H, Nguyen D, Roberts D; PHE Virology group; Zambon M; Oxford collaborative group; Townsend A; Bergen COVID-19 Research Group; Langeland N, Cox RJ. Ertesvåg NU, et al. Among authors: schimanski l. Commun Med (Lond). 2022 Apr 5;2:36. doi: 10.1038/s43856-022-00091-x. eCollection 2022. Commun Med (Lond). 2022. PMID: 35603265 Free PMC article.
54 results